⌘K

Login Start Free

Home/Filings/4/0001171843-20-001361

4//SEC Filing

VOGT SUSAN L N 4

Accession 0001171843-20-001361

CIK 0000898437other

View on SEC.gov Company Profile

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 6:52 PM ET

Size

4.9 KB

Accession

0001171843-20-001361

Insider Transaction Report

Form 4

Period: 2020-02-25

Anika Therapeutics, Inc.ANIK

Director

Transactions

Award
Common Stock
2020-02-25+4,107→ 11,652 total

Footnotes (1)

[F1]These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on February 25, 2021.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Anika Therapeutics, Inc.

CIK 0000898437

Entity typeother

Related Parties

1

filerCIK 0001191270

Filing Metadata

Form type: 4
Filed: Feb 26, 7:00 PM ET
Accepted: Feb 27, 6:52 PM ET
Size: 4.9 KB

View on SEC.gov